The Food and Drug Administration (FDA) conducted an inspection of NVE Pharmaceuticals, Inc. in Andover on March 20, based on details published on the FDA’s website.
Areas reviewed during the inspection included:
- Food Composition, Standards, Labeling and Econ
- Foodborne Biological Hazards
The final report noted that NVE Pharmaceuticals, Inc. was not required to make any changes to how its operations are managed.
The FDA regularly inspects locations nationwide to evaluate whether facilities and their products comply with laws and regulations the agency enforces to ensure public health. Findings from these inspections are made available to the public.
The FDA’s website describes the agency as responsible for overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
